Who invested in CellCentric?
5 investors are on record as having backed CellCentric — Develops cancer drug targeting p300/CBP, in Biotech, United States. Each row below says whether the round came from the investor's own portfolio page or from the press.
cellcentric.comCellCentric investors
HBM Partners Hong Kong LimitedBacks biopharma, medtech, diagnostics and healthcare companies from venture to buy-out…growth$220MMay 2026press
Avego Bioscience CapitalBacks companies developing and commercializing innovative healthcare products and…growth$220MJan 2025press
3 more investors on record for CellCentric.
The first two are open to everyone. A free account opens the rest — the fund, the round, the amount and where each number came from. No card, no demo call.
The funds that backed CellCentric are in the directory.
If they wrote this cheque, they may write yours. Pitch2Fund scores your startup against every one of them, gives you the partner to write to, and drafts the email. Free.